Elsevier

Human Pathology

Volume 27, Issue 1, January 1996, Pages 20-27
Human Pathology

Original contribution
Epstein-barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation,☆☆

https://doi.org/10.1016/S0046-8177(96)90133-1Get rights and content

Abstract

Ninety-five cases of adenocarcinoma of the stomach were evaluated for the presence of Epstein-Barr virus (EBV) using a sensitive in situ hybridization assay targeting Epstein-Barr virus—encoded RNA 1 (EBER1) transcripts. EBER1 was detected in 11 of 95 (12%) of cases. When present, the virus was localized to malignant epithelial cells and to dysplastic gastric epithelium, but was not seen in normal-appearing gastric epithelium or intestinal metaplasia. The EBV DNA was monoclonal in all three cases tested by Southern blot analysis of the EBV terminal repeat fragment. These findings suggest that the virus was present before malignant transformation. The presence of EBV was strongly associated with increased numbers of tumor-infiltrating T lymphocytes; however, EBV was not associated with prolonged survival. Neither p53 nor bcl-2 were consistently detected in the EBV-associated tumors. Specifically, 6 of 11 EBV-positive carcinomas had accumulation of p53 protein by immunohistochemical analysis, which was similar to the prevalence of p53 accumulation in EBV-negative specimens and suggests that EBV infection does not substitute for p53 mutation during tumorigenesis. The bcl-2 oncoprotein was expressed in a third of the carcinoma specimens tested, but bcl-2 expression did not correlate with the presence of EBV or with expression of EBV latent membrane protein 1. In conclusion, EBV infection appears to precede malignant transformation in a significant fraction of gastric carcinomas, but neither bcl-2 expression nor p53 accumulation appear to be consistently associated with the presence of the virus.

References (62)

  • G Niedobitek et al.

    Epstein-Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cells carcinomas of the nasopharynx are regularly associated with the virus

    J Pathol

    (1991)
  • D Shibata et al.

    Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration

    Am J Pathol

    (1991)
  • S Shousha et al.

    Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa

    J Clin Pathol

    (1994)
  • L Leoncini et al.

    Epstein-Barr virus and gastric cancer: Data and unanswered questions

    Int J Cancer

    (1993)
  • AP Burke et al.

    Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction

    Mod Pathol

    (1990)
  • M Mori et al.

    Epstein-Barr virus-associated carcinomas of the esophagus and stomach

    Arch Pathol Lab Med

    (1994)
  • G Niedobitek et al.

    Epstein-Barr virus and carcinomas

    Diagn Mol Path

    (1992)
  • Y Takano et al.

    Epstein-Barr-virus-associated medullary carcinomas with lymphoid infiltration of the stomach

    J Cancer Res Clin Oncol

    (1994)
  • K-W Min et al.

    Poorly differentiated adenocarcinoma with lymphoid stroma (lymphoepithelioma-like carcinomas of the stomach): Report of three cases with Epstein-Barr virus genome demonstrated by the polymerase chain reaction

    Am J Clin Pathol

    (1991)
  • G Ott et al.

    Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma

    Histopathology

    (1994)
  • S Pittaluga et al.

    Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the stomach: Demonstration of viral genome by in situ hybridization and Southern blot analysis

    Mod Pathol

    (1992)
  • DC Rowlands et al.

    Epstein-Barr virus and carcinomas: Rare association of the virus with gastric adenocarcinomas

    Br J Cancer

    (1993)
  • D Shibata et al.

    Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii

    Cancer Epidemiol Biomarkers Prev

    (1993)
  • ST Yuen et al.

    In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas

    Am J Surg Pathol

    (1994)
  • M Tokunaga et al.

    Epstein-Barr virus related gastric cancer in Japan: A molecular pathoepidemiological study

    Acta Pathol Jpn

    (1993)
  • D Shibata et al.

    Epstein-Barr virus-associated gastric carcinoma

    Am J Pathol

    (1992)
  • S Imai et al.

    Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

  • M Tokunaga et al.

    Epstein-Barr virus in gastric carcinoma

    Am J Pathol

    (1993)
  • PH Levine et al.

    Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr virus associated gastric adenocarcinoma

    Int J Cancer

    (1995)
  • Y-H Shiao et al.

    p53 alteration in gastric precancerous lesions

    Am J Pathol

    (1994)
  • Q Zhang et al.

    Functional and physical interaction between p53 and BZLF1: Implications for Epstein-Barr virus latency

    Mol Cell Biol

    (1994)
  • Cited by (0)

    Supported by grants from the National Institutes of Health (K08-CA01615 and P30-CA54174), American Cancer Society, Veteran's Administration, South Texas Health Research Center, and the San Antonio Cancer Institute Pathology Core.

    ☆☆

    This is a US government work. There are no restrictions on its use.

    View full text